9.1 Occupational Health Surveillance Programs (Hearing Conservation, Respiratory Protection)

9.1 Occupational Health Surveillance Programs (Hearing Conservation, Respiratory Protection)

Quick Summary: Occupational health surveillance combines hazard surveillance (monitoring environmental stressors) with medical surveillance (systematic evaluation of worker biological data). OSHA standards establish mandatory, substance-specific and program-specific medical surveillance for noise exposure (29 CFR 1910.95), respiratory hazards (29 CFR 1910.134), lead (29 CFR 1910.1025), asbestos (29 CFR 1910.1001), and benzene (29 CFR 1910.1028). The Occupational Health Nurse (OHN) plays a pivotal role in administering baseline, periodic, and exit examinations, identifying standard threshold shifts, conducting respirator medical clearances, and managing medical removal protection.

Medical Surveillance vs. Hazard Surveillance

A comprehensive occupational safety and health management system relies on two complementary branches of surveillance:

1. Hazard Surveillance: The systematic collection, analysis, and interpretation of environmental exposure data in the workplace. Industrial hygienists measure physical, chemical, biological, and ergonomic hazards through air sampling, direct-reading instruments, noise dosimeters, and area sound-level mapping. The primary objective is to evaluate compliance with OSHA Permissible Exposure Limits (PELs) and Threshold Limit Values (TLVs) established by ACGIH, identifying engineering control failures before workers sustain injury or illness.
2. Medical Surveillance: The targeted, ongoing assessment of individual worker health data to detect early, subclinical physiological changes or toxicological effects resulting from occupational exposures. While hazard surveillance assesses the environment, medical surveillance assesses the biological response of the human host.

Examination Framework: Baseline, Periodic, and Exit Examinations

Occupational health nursing practice structures medical surveillance around three essential exam milestones:

• Baseline (Pre-Placement / Pre-Assignment) Examination: Conducted prior to an employee beginning work in a designated high-risk role or exposure zone. The baseline exam establishes an individual's reference health profile, identifies pre-existing medical conditions, evaluates physical and physiological fitness for duty, and provides baseline clinical data (e.g., initial audiogram, baseline pulmonary function testing, baseline blood lead level) against which all future periodic tests are compared.
• Periodic Examination: Performed at scheduled intervals (typically annual, biennial, or semi-annual based on regulatory standards and hazard severity). Periodic exams monitor long-term health trends, detect subclinical biological changes (e.g., early hearing loss, elevated heavy metal biomarkers, subtle decline in lung volume), and assess the real-world efficacy of workplace engineering controls and personal protective equipment (PPE).
• Exit (Termination of Employment / Reassignment) Examination: Administered when an employee leaves a role involving targeted hazardous exposures or terminates employment. The exit exam documents the worker's health status at the end of exposure, establishes a final clinical record for workers' compensation and medico-legal baseline defense, and provides mandatory post-exposure counseling regarding latent health effects (e.g., long latency periods of asbestos-related mesothelioma or silica-induced pneumoconiosis).

---

Hearing Conservation Program (OSHA 29 CFR 1910.95)

Noise-induced hearing loss (NIHL) is sensorineural, bilateral, permanent, and entirely preventable. The OSHA Hearing Conservation Standard (29 CFR 1910.95) establishes strict requirements for employers when worker noise exposures equal or exceed designated action thresholds.

Action Level vs. Permissible Exposure Limit (PEL)

• Action Level (AL): An 8-hour Time-Weighted Average (TWA) noise exposure of 85 decibels A-weighted (dBA), corresponding to a 50% noise dose. Reaching or exceeding 85 dBA TWA mandates immediate inclusion of affected workers in a formal Hearing Conservation Program (HCP), including annual audiometric testing, training, and provision of hearing protection devices (HPDs) at no cost.
• Permissible Exposure Limit (PEL): An 8-hour TWA of 90 dBA (100% dose). When exposures equal or exceed 90 dBA TWA, employers are legally obligated to implement engineering controls (e.g., equipment enclosures, acoustic baffles) or administrative controls (e.g., rotating worker shifts) to reduce sound levels below 90 dBA. HPDs are mandatory for all workers exposed at or above 90 dBA, or those exposed at 85 dBA who have not yet had a baseline audiogram or have experienced a hearing loss.
• OSHA 5 dB Exchange Rate: OSHA uses a 5 dB exchange rate, meaning that for every 5 dBA increase in noise level, the allowed exposure time is reduced by half (e.g., 90 dBA is permitted for 8 hours, 95 dBA for 4 hours, 100 dBA for 2 hours, and 105 dBA for 1 hour).

Baseline & Annual Audiometric Testing Protocols

• Baseline Audiogram: Must be established within 6 months of an employee's first exposure at or above the Action Level of 85 dBA TWA (extended to 12 months if a mobile test van is utilized, provided the worker wears mandatory hearing protection after 6 months until tested). Testing must be preceded by at least 14 hours without exposure to workplace noise exceeding 80 dBA. Hearing protection devices may be used to satisfy the 14-hour quiet period requirement. Audiometric test frequencies evaluated include 500, 1000, 2000, 3000, 4000, and 6000 Hz in each ear.
• Annual Audiogram: Administered at least annually to every worker exposed at or above 85 dBA TWA. Each annual audiogram is statistically compared against the worker's baseline audiogram to evaluate hearing acuity changes.

Standard Threshold Shift (STS) & Follow-Up Protocols

A Standard Threshold Shift (STS) is defined by OSHA as a change in hearing threshold relative to the baseline audiogram of an average of 10 dB or more at 2000, 3000, and 4000 Hz in either ear.

• Age Correction: Employers are permitted, but not required, to apply OSHA age-correction tables to adjust for presbycusis (age-related hearing loss) when determining if an STS has occurred.
• Retest Protocol: If an annual audiogram indicates an STS, the employer may conduct a retest within 30 days to confirm or rule out the shift. If the retest confirms STS (or if no retest is conducted), the shift is deemed persistent.
• Mandatory Follow-Up Actions: Within 21 calendar days of determination, the employer must provide written notification to the employee. The OHN must ensure the worker is refitted with appropriate HPDs, retrained on proper insertion and care, and required to wear HPDs if exposed to 85 dBA TWA or higher. If the nurse or physician suspects a medical pathology of the ear caused or aggravated by HPD use, the worker is referred for an otological evaluation.
• OSHA Form 300 Recording: An STS is recordable on the OSHA 300 Log if the shift represents a persistent STS (10 dB average shift at 2, 3, and 4 kHz) AND the worker's total hearing level in the same ear is 25 dB or higher above audiometric zero at those same frequencies.

Hearing Protection Device (HPD) Noise Reduction Rating (NRR) Derating

Laboratory Noise Reduction Ratings (NRR) printed on HPD packaging overestimate real-world protection due to improper fitting, poor maintenance, and user adjustment errors. OSHA requires employers to calculate real-world derated NRR to verify adequate noise attenuation.

When ambient noise is measured in dBA, OSHA applies the mandatory 7 dB C-weighted conversion factor and a 50% safety derating factor:

$\text{Estimated Protected Exposure (dBA)} = \text{Noise Level (dBA)} - \left[ \frac{\text{NRR} - 7}{2} \right]$

Example Calculation: A worker is exposed to an 8-hour TWA noise level of 95 dBA and wears earplugs with a labeled laboratory NRR of 25 dB.

1. Subtract 7 dB for C-weighting correction: $25 - 7 = 18\text{ dB}$.
2. Apply 50% derating: $18 / 2 = 9\text{ dB}$ of effective real-world protection.
3. Calculate protected exposure: $95\text{ dBA} - 9\text{ dB} = 86\text{ dBA}$. Clinical Assessment: Because 86 dBA exceeds the 85 dBA Action Level, this single hearing protector is insufficient. The worker requires higher NRR protection or dual protection (earplugs plus earmuffs). When dual protection is worn, OSHA guidelines specify adding 5 dB of attenuation to the higher derated protector's NRR rather than combining NRR values additively.

---

Respiratory Protection Program (OSHA 29 CFR 1910.134)

OSHA 29 CFR 1910.134 mandates a comprehensive, written Respiratory Protection Program whenever respirators are required to protect employees from contaminated workplace air (dusts, mists, fumes, vapors, gases, or oxygen-deficient atmospheres).

Mandatory Program Elements & Administration

The program must be administered by a qualified Program Administrator and contain written worksite-specific procedures for:

1. Respirator selection based on hazard characteristics and Assigned Protection Factors (APF).
2. Medical evaluation of employees designated to wear respirators.
3. Annual fit testing procedures.
4. Proper use, maintenance, cleaning, storage, and inspection.
5. Air quality monitoring for supplied-air respirators (Grade D breathable air).
6. Mandatory annual employee training.

Medical Evaluation by PLHCP

Before an employee can be fit tested or required to wear any respirator (negative or positive pressure), they must receive a medical evaluation conducted by a Physician or Other Licensed Health Care Professional (PLHCP), such as an Occupational Health Nurse Practitioner or Occupational Physician.

• Mandatory OSHA Medical Questionnaire: The PLHCP evaluates the employee using the mandatory questionnaire provided in Appendix C of 29 CFR 1910.134, or conducts a physical exam that yields the same information.
• Clinical Focus Areas: Assessment of underlying cardiovascular conditions (e.g., ischemic heart disease, hypertension), respiratory pathology (e.g., asthma, COPD, reduced vital capacity), claustrophobia, facial skin conditions, and neurological disorders. Respirator wear increases breathing resistance, dead-space heat accumulation, and cardiac workload.
• PLHCP Written Recommendation: The PLHCP provides a written recommendation to the employer and employee stating:
  • Whether the employee is medically cleared to wear a respirator without restrictions, cleared with specific restrictions (e.g., limited to 2 hours per shift), or not cleared.
  • Any need for follow-up medical evaluations.
  • Statement that the PLHCP has provided the employee with a copy of the written recommendation.
  • If a negative-pressure respirator is medically contraindicated, the PLHCP must evaluate whether the worker can safely use a Powered Air-Purifying Respirator (PAPR), which places significantly less strain on the respiratory system.

Qualitative vs. Quantitative Fit Testing

Fit testing evaluates the facepiece-to-face seal to prevent inward leakage of contaminated air. Fit testing must be performed prior to initial use, at least annually, and whenever there is a change in respirator model/size or physical changes in the worker (e.g., facial scarring, dental changes, cosmetic surgery, or major weight gain/loss).

• Qualitative Fit Testing (QLFT): A pass/fail test method relying on the wearer's sensory response (taste or smell) to a test agent. Standard agents include isoamyl acetate (banana oil), saccharin solution, Bitrex (denatonium benzoate), and irritant smoke (stannic chloride). QLFT is strictly limited to negative-pressure air-purifying respirators that achieve a maximum Assigned Protection Factor (APF) of 10 (e.g., half-mask filtering facepieces like N95s or half-mask elastomeric respirators).
• Quantitative Fit Testing (QNFT): An objective numerical measurement of respirator facepiece leakage using specialized instrumentation (e.g., PortaCount condensation nuclei counter or Controlled Negative Pressure device). QNFT calculates a numerical Fit Factor ratio (ambient particle concentration vs. in-mask particle concentration). QNFT is mandatory for full-facepiece respirators requiring an APF of 50 or higher. Full-facepiece respirators require a minimum Fit Factor of 500 to pass QNFT, whereas half-mask respirators require a minimum Fit Factor of 100.

User Seal Check & Facial Hair Restrictions

• User Seal Check: Conducted by the employee every single time they don a tight-fitting respirator before entering a hazardous atmosphere. It consists of a positive pressure check (covering the exhalation valve and exhaling gently; facepiece should puff out slightly without leakage) and a negative pressure check (covering the filter inlets and inhaling gently; facepiece should collapse slightly onto the face). Critical Distinction for Exam: A user seal check is an operational donning check, NOT a substitute for a formal annual fit test.
• Facial Hair Restrictions: OSHA strictly prohibits tight-fitting respirators from being worn by employees who have facial hair (beards, long stubble, sideburns) that lies between the sealing surface of the facepiece and the skin or interferes with valve function. Even one day's stubble growth can compromise facepiece seal integrity by multiple orders of magnitude.

---

Substance-Specific OSHA Medical Surveillance Standards

OSHA enforces chemical-specific standards containing expanded health surveillance requirements when workplace exposures exceed action levels.

Lead Standard (29 CFR 1910.1025)

The lead standard protects workers against chronic occupational lead toxicity (saturnism), which causes anemia, peripheral neuropathy, nephropathy, hypertension, and reproductive toxicity.

• Biological Monitoring: Evaluates Blood Lead Levels (BLL) and Zinc Protoporphyrin (ZPP). Baseline testing is required for all workers exposed above the Action Level (30 µg/m³ TWA) for more than 30 days per year. Periodic BLL/ZPP monitoring must occur at least every 6 months. If a worker's BLL reaches 40 µg/dL or higher, monitoring frequency must increase to at least every 2 months until two consecutive tests show BLLs below 40 µg/dL.
• Medical Removal Protection (MRP): Mandatory medical removal from lead-exposed work is triggered when a single blood lead test result is at or above 60 µg/dL, or when the average of the last three BLL tests (or all tests over the prior 6 months) is at or above 50 µg/dL. Under MRP, the employee must be removed to a job with lead exposure below the action level while maintaining their full earnings, seniority, and employment rights. Return to lead-exposed work is permitted only when two consecutive BLL tests drop below 40 µg/dL.

Asbestos Standard (29 CFR 1910.1001)

Asbestos exposure leads to progressive pulmonary fibrosis (asbestosis), lung cancer, and malignant mesothelioma.

• Medical Examination Protocol: Mandatory pre-placement, annual, and exit examinations for employees exposed above the PEL (0.1 fiber/cc TWA) or excursion limit.
• Key Clinical Diagnostic Elements:
  • Comprehensive medical and occupational history focusing on respiratory symptoms.
  • Chest radiographs: Posterior-anterior (PA) chest X-rays must be classified according to the ILO international classification system by a certified B-Reader radiologist to detect pleural plaques, thickening, and interstitial parenchymal changes.
  • Pulmonary Function Testing (PFT): Spirometry measuring Forced Vital Capacity (FVC) and Forced Expiratory Volume in 1 Second (FEV1) administered by a NIOSH-approved technician.
• Record Retention: All asbestos medical surveillance records must be maintained by the employer for the duration of employment plus 30 years (29 CFR 1910.1020).

Benzene Standard (29 CFR 1910.1028)

Benzene is an aromatic hydrocarbon and known human carcinogen targeting the hematopoietic system, causing aplastic anemia, myelodysplastic syndrome, and acute myelogenous leukemia (AML).

• Surveillance Protocol: Pre-placement, annual, and exit medical examinations for workers exposed at or above the Action Level (0.5 ppm TWA) for 30 or more days per year.
• Hematological Monitoring: Mandatory Complete Blood Count (CBC) with differential and quantitative platelet count at baseline and annually.
• Clinical Trigger & Referral: If serial CBC monitoring reveals a persistent decline in leukocyte count (WBC < 4,000/mm³), red cell counts, or platelet count (platelets < 150,000/mm³), or an absolute neutrophil count below 2,000/mm³, the OHN must arrange immediate referral to a board-certified hematologist for bone marrow evaluation and trigger mandatory workplace exposure re-evaluation.